Follow-on biologics hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
|Format:||Government Document Online Book|
|Series:||S. hrg. ;
|Online Access:||ONLINE VERSION|
No Tags, Be the first to tag this record!
by: Geigert, J. 1948-
by: Johnson, Judith A. 1957-
by: Storz, Ulrich, 1969-
by: Sasson, Albert.
by: Uecke, Oliver.
by: Mellon, Jim.
by: Mehta, Shreefal S.